JENNIFER CHURCHILL: Open Payments
NPI 1518443514 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,272 in 47 payments from 13 companies in 2025. Trend: 2023 $1,197 · 2024 $1,217 · 2025 $1,272
Food & beverage: $1,272
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 5 | $223 |
| AstraZeneca Pharmaceuticals LP | 5 | $191 |
| BridgeBio Pharma, Inc. | 4 | $165 |
| Amgen Inc. | 3 | $92 |
| Actelion Pharmaceuticals US, Inc. | 3 | $90 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $90 |
| E.R. Squibb & Sons, L.L.C. | 4 | $89 |
| Novartis Pharmaceuticals Corporation | 3 | $85 |
| PFIZER INC. | 4 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
Products named: ONPATTRO, Attruby, OPSUMIT, LifeVest, LEQVIO, Kerendia, ELIQUIS, CAMZYOS.
Industry payments across MI — which companies pay providers there.
